COMMUNIQUÉS West-GlobeNewswire

Women’s Health Collective Canada Launches Vital Talks National Seminar Series with the Support of Vichy Laboratoires
15/09/2025
From menopause to menstruation and beyond, Vital Talks bring vital science to women at every stage of their health journey TORONTO, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Women’s Health Collective Canada (WHCC) is proud to [...]
L’Association canadienne pour l’équité en santé des femmes (ACESF) lance la série de séminaires nationaux Conversations vitales avec le soutien de Vichy Laboratoires
15/09/2025
De la ménopause aux menstruations et plus encore, Conversations vitales fournit des renseignements scientifiques importants aux femmes à chaque étape de leur parcours de santé TORONTO, 15 sept. 2025 (GLOBE NEWSWIRE) -- [...]
AdCare Rhode Island Appoints New Executive Director as Facility Expansion Nears Completion to Serve More People Struggling with Addiction
15/09/2025
NORTH KINGSTOWN, Rhode Island, Sept. 15, 2025 (GLOBE NEWSWIRE) -- AdCare Rhode Island has appointed Nicole Paliotti as its new Executive Director. As a trusted healthcare leader who has served the Rhode Island community [...]
HNL Lab Medicine Receives Accreditation from College of American Pathologists
15/09/2025
ALLENTOWN, Pa., Sept. 15, 2025 (GLOBE NEWSWIRE) -- The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to HNL Lab Medicine Acute Care Labs located in Macungie and [...]
Kyverna Therapeutics to Highlight Interim Phase 2 Data from KYV-101 KYSA-6 Study in Myasthenia Gravis at AANEM 2025
15/09/2025
Oral presentation to include topline efficacy and safety data for 6 patients with up to 9 months of follow up Enrollment for registrational Phase 3 portion of KYSA-6 trial in MG on track to initiate by year-end 2025 [...]
Press release: SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM
15/09/2025
SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM Ghent, Belgium, 15 September 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " [...]
Guerbet : Adjustment of 2025 full-year financial targets
15/09/2025
Adjustment of 2025 full-year financial targets Villepinte, 15 September 2025, 5.45 p.m. : Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is announcing a downward [...]
Guerbet : Ajustement des objectifs financiers annuels 2025
15/09/2025
Ajustement des objectifs financiers annuels 2025 Villepinte, le 15 septembre 2025, 17h45 : Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l’imagerie médicale, annonce une [...]
Organic & Natural Health Leads First-Ever My Health Alliance Lobby Day on Capitol Hill
15/09/2025
WASHINGTON, Sept. 15, 2025 (GLOBE NEWSWIRE) -- On Sept. 10, more than 50 citizen lobbyists representing a consortium of 15 national nonprofits and organizations gathered on Capitol Hill for the first My Health Alliance [...]
Smile Hair Clinic Becomes the First Hair Transplant Clinic in the World to Receive A-Rated Certificate from TEMOS
15/09/2025
ISTANBUL, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Smile Hair Clinic has been awarded an A rating by TEMOS International Healthcare Accreditation, one of the most respected global organizations for quality and safety in [...]
ProteoNic Launches 2G UNic Transposon Platform to Support Superior Cell Line Productivity and Ease of Use
15/09/2025
Leiden, The Netherlands – September 15, 2025 – ProteoNic , a leader in premium vector technology for biologics and cell and gene therapy, today announced the launch of its novel 2G UNic® transposon platform, available [...]
Interpace Biosciences Presented Two New Posters at the 2025 American Thyroid Association® (ATA) Annual Meeting
15/09/2025
Highlights Independent institutional experience shows archival cytology slides enabled successful molecular results in cases previously insufficient for testing by another commercially available molecular diagnostic [...]
Berry Street Launches GLP-1 Nutrition Pathway Program
15/09/2025
New Comprehensive Program Supports Patients Throughout Entire GLP-1 Journey NEW YORK, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Berry Street , an AI-powered nutrition therapy platform, today announced the launch of its GLP-1 [...]
Botany Scientifics Wins “Top Full Spectrum Hemp Products 2025” Award from Cannabis Business Insights Magazine
15/09/2025
Texas hemp company recognized for exceptional quality, precision dosing, and pioneering consumer education SAN ANTONIO, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Botany Scientifics, a family-owned Texas hemp company [...]
Assertio Presents First-Ever Real-World Study Showing Patient Experience with SYMPAZAN® (clobazam) Oral Film, CIV
15/09/2025
New data show how Sympazan is being used in daily clinical practice to treat patients with Lennox-Gastaut Syndrome (LGS), a severe form of childhood-onset epilepsy Study addresses lack of awareness and real-world data [...]
Conceivable Life Sciences Secures $50 Million Series A
15/09/2025
Funding supports U.S. market launch of AURA, World’s first AI-powered automated IVF lab NEW YORK, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Conceivable Life Sciences today announced its $50 million Series A financing to [...]
Entera Bio Reports Positive PK Data for First-in-Class Oral GLP-2 Tablet Treatment for Patients with Short Bowel Syndrome at the 2025 ESPEN Congress
15/09/2025
Preclinical Data for OPK-8801003 Demonstrate Substantially Longer Biological Half-Life with Peak Plasma Levels Comparable to Gattex ® , the Only Approved GLP-2 Therapy Oral GLP-2 Tablet Could Transform Treatment [...]
Press Release Biocartis NV: Biocartis Receives FDA Approval for the Idylla™ CDx MSI Test
15/09/2025
PRESS RELEASE - 09/15/2025, 09:00 AM EDT Biocartis Receives FDA Approval for the Idylla™ CDx MSI Test First-ever fully automated, sample-to-result, cartridge-based companion diagnostic test approved in the US for [...]
Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain
15/09/2025
GAITHERSBURG, Md., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received a $17 million contract modification from the Biomedical Advanced Research and Development [...]

Pages